Related Experiment Video
Updated: Feb 22, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Targeting RNA helicases in cancer: The translation trap
Marise R Heerma van Voss1, Paul J van Diest2, Venu Raman3
1Department of Radiology and Radiological Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract:
Cancer cells are reliant on the cellular translational machinery for both global elevation of protein synthesis and the translation of specific mRNAs that promote tumor cell survival. Targeting translational control in cancer is therefore increasingly recognized as a promising therapeutic strategy. In this regard, DEAD/H box RNA helicases are a very interesting group of proteins, with several family members regulating mRNA translation in cancer cells. In this review, we delineate the mechanisms by which DEAD/H box proteins modulate oncogenic translation and how inhibition of these RNA helicases can be exploited for anti-cancer therapeutics.
Insights
Targeting cancer cell translation machinery, specifically DEAD/H box RNA helicases, offers a promising therapeutic strategy. Inhibiting these RNA helicases can disrupt tumor cell survival and protein synthesis for anti-cancer treatments.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Cancer cells depend on protein synthesis for survival and growth.
- Translational control is a key regulatory mechanism in cancer.
- DEAD/H box RNA helicases play significant roles in mRNA translation.
Purpose of the Study:
- To review the mechanisms by which DEAD/H box proteins regulate oncogenic translation.
- To explore the therapeutic potential of targeting these RNA helicases in cancer.
Main Methods:
- Literature review of studies on DEAD/H box proteins in cancer.
- Analysis of molecular mechanisms of translational control.
- Discussion of therapeutic strategies targeting RNA helicases.
Main Results:
- DEAD/H box proteins are crucial regulators of protein synthesis in cancer cells.
- Specific DEAD/H box family members are implicated in promoting tumor cell survival.
- Inhibition of these helicases presents a viable anti-cancer therapeutic approach.
Conclusions:
- Targeting translational control via DEAD/H box RNA helicases is a promising cancer therapy.
- Understanding these mechanisms can lead to novel anti-cancer drug development.
Related Concept Videos
Leaky Scanning
DNA Helicases
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Targeted Cancer Therapies
There are several types of targeted therapies against...

